Skip to main content
SpringerLink
Log in

Rituximab

Worsening of COVID-19 infection: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sanchez-Fernandez PSA, et al. Evaluation of the possible different evolution of SARS-CoV-2 infection with tumor necrosis factor inhibitors or with rituximab in rheumatic. Arthritis and Rheumatology 73 (Suppl.): 3200-3202, Sep 2021. Available from: URL: http://doi.org/10.1002/art.41966 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rituximab. Reactions Weekly 1913, 388 (2022). https://doi.org/10.1007/s40278-022-18538-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-18538-2

Search

Navigation